Skip to content

Effects of Preconditioning by nasal splint and mouth-breathing on Emergence Delirium after FESS in adults

Preconditioning by nasal splint and mouth breathing training reduce emergence delirium after Functional Endoscopic Sinus Surgery in adults: a randomised controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900024925
Enrollment
Unknown
Registered
2019-08-03
Start date
2019-07-29
Completion date
Unknown
Last updated
2019-08-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Emergence agitation / Emergence delirium

Interventions

P-group:Nasal splint
C-group:None

Sponsors

Shanghai General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1) patients undergoing FESS surgery in Shanghai General hospital; 2) over 18 years old; 3) ASA I-II; 4) preoperative examination of liver and kidney function within the normal range; 5) Those who, through publicity and mobilization, know about the experiment and voluntarily participate in signing the informed consent.

Exclusion criteria

Exclusion criteria: 1) With severe cardiovascular disease or poor blood pressure control; 2) history of mental illness; 3) taking sedatives or psychotics (neuroinhibitors, anti-anxiety drugs, antidepressants, benzodiazepines) for any reason; 4) history of neurological diseases (cerebral infarction, transient ischemic attack, Parkinson's disease, mental retardation, craniocerebral injury); 5) nasal malformation, history of nasal trauma, after the implantation of nasal prosthesis; 6) surgical complications (socket perforation, massive bleeding requiring blood transfusion or reoperation, cerebrospinal fluid leakage, eyelid emphysema, intraorbital bleeding, meningitis, partial loss of vision, double vision, blindness, death).

Design outcomes

Primary

MeasureTime frame
The Sedation Agitation Scale;The degree of agitation evaluation;

Secondary

MeasureTime frame
Pain assessment;

Countries

China

Contacts

Public ContactXu Hongjiao

Shanghai General Hospital

gillianxu1987@163.com+86 18917909818

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 17, 2026